All Stories

  1. αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans
  2. Cognitive control predicted by color vision, and vice versa
  3. Differential effects of MDMA and methylphenidate on social cognition
  4. Cognitive Impairment in Cocaine Users is Drug-Induced but Partially Reversible: Evidence from a Longitudinal Study
  5. Functional changes of the reward system underlie blunted response to social gaze in cocaine users
  6. Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective
  7. Differences in self-reported and behavioral measures of impulsivity in recreational and dependent cocaine users
  8. MDMA enhances emotional empathy and prosocial behavior
  9. Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users
  10. Neural representation and clinically relevant moderators of individualised self-criticism in healthy subjects
  11. Altered social and non-social decision-making in recreational and dependent cocaine users
  12. Impaired emotional empathy and related social network deficits in cocaine users
  13. Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset
  14. Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans
  15. The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism
  16. Verbal Memory Deficits Are Correlated with Prefrontal Hypometabolism in 18FDG PET of Recreational MDMA Users
  17. Elektrokonvulsionstherapie als Ultima Ratio in der Behandlung der Depression?
  18. Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls
  19. Increased Sensorimotor Gating in Recreational and Dependent Cocaine Users Is Modulated by Craving and Attention-Deficit/Hyperactivity Disorder Symptoms
  20. Cocaine Users Manifest Impaired Prosodic and Cross-Modal Emotion Processing
  21. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics
  22. Blue–yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users
  23. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography
  24. Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach
  25. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response
  26. Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy
  27. Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
  28. Impact of TCF4 on the genetics of schizophrenia
  29. Reconsidering GHB: orphan drug or new model antidepressant?
  30. The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms
  31. The Schizophrenia Risk Allele C of the TCF4 rs9960767 Polymorphism Disrupts Sensorimotor Gating in Schizophrenia Spectrum and Healthy Volunteers
  32. Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers
  33. Ethics of neuroenhancement: A phantom debate
  34. Serotonin and Schizophrenia
  35. Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia
  36. DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis
  37. Startle cue–reactivity differentiates between light and heavy smokers
  38. Sensorimotor Gating Depends on Polymorphisms of the Serotonin-2A Receptor and Catechol-O-Methyltransferase, but Not on Neuregulin-1 Arg38Gln Genotype: A Replication Study
  39. GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies
  40. Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
  41. Impaired Sensorimotor Gating of the Acoustic Startle Response in the Prodrome of Schizophrenia
  42. From genes to psychoses and back: the role of the 5HT2α-receptor and prepulse inhibition in schizophrenia
  43. Sensorimotor Gating of Schizophrenia Patients Is Influenced by 5-HT2A Receptor Polymorphisms
  44. Sensorimotor Gating of Schizophrenia Patients Depends on Catechol O-Methyltransferase Val158Met Polymorphism
  45. Schizophrenie und Religiosität – Eine Vergleichsstudie zur Zeit der innerdeutschen Teilung
  46. Analgesic and neuropsychological effects of Echinacea N-alkylamides
  47. Executive performance of depressed suicide attempters: the role of suicidal ideation
  48. Sensorimotor gating and attentional set-shifting are improved by the μ-opioid receptor agonist morphine in healthy human volunteers
  49. Defizite der sensomotorischen Filterleistung bei psychiatrischen Erkrankungen
  50. On the influence of baseline startle reactivity on the indexation of prepulse inhibition.
  51. Neuropsychological performance in partly remitted unipolar depressive patients: focus on executive functioning
  52. The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval
  53. The monotonic dependency of prepulse inhibition of the acoustic startle reflex on the intensity of the startle-eliciting stimulus
  54. Normal prepulse inhibition and habituation of acoustic startle response in suicidal depressive patients without psychotic symptoms
  55. Attenuation of the prepulse inhibition of the acoustic startle response within and between sessions
  56. Sensorimotor Gating and Habituation of the Startle Response in Schizophrenic Patients Randomly Treated With Amisulpride or Olanzapine
  57. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”)
  58. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction
  59. Impaired Prepulse Inhibition of Acoustic Startle in Obsessive-Compulsive Disorder
  60. Cognitive Improvement in Schizophrenic Patients does not Require a Serotonergic Mechanism: Randomized Controlled Trial of Olanzapine vs Amisulpride
  61. Neuroimaging and 5-HT 2C Receptor Polymorphism: A HMPAO-SPECT Study in Healthy Male Probands Using mCPP-Challenge of the 5-HT 2C Receptor
  62. Lebensqualität und Therapieerfolg in der ambulanten Schizophrenie-Therapie mit Flupentixol: Eine Anwendungsbeobachtung
  63. Usefulness of Bromocriptine in the Treatment of Amisulpride-induced Hyperprolactinemia
  64. Prepulse Inhibition and Habituation of Acoustic Startle Response in Male MDMA (‘Ecstasy’) Users, Cannabis Users, and Healthy Controls
  65. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants
  66. Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression
  67. Allelic Variants of the Serotonin 2C Receptor and Neuroendocrinological Responses to the Serotonin 2C Receptor Agonist m-Chlorophenylpiperazine in Healthy Male Volunteers
  68. Chronifizierung und psychosoziale Behinderung durch depressive Erkrankungen bei Patienten in der Allgemeinarztpraxis im Einjahresverlauf Ergebnisse aus einer Studie der Weltgesundheitsorganisation